47

Articles

35

Sources

55%

Analysis & opinion

The reporting

A neutral summary of the key facts most outlets agree on, drawn from reporting across the political spectrum.

The Pentagon has not provided a cost estimate for Defense Secretary Pete Hegseth’s annual testosterone-screening mandate, which would cover roughly 2 million active-duty and reserve service members age 30 and older. Troops under 30 may request screening, and those deemed deficient could be offered testosterone replacement therapy under military medical supervision. Hegseth frames the program as a readiness measure, but physicians say broad screening of healthy personnel has uncertain benefits and could spur unnecessary prescriptions with risks including infertility.

Day 5

Latest update · Jul 20

The Pentagon has not released a cost estimate for the new annual testosterone-screening mandate, which would apply to roughly 2 million active-duty and reserve personnel age 30 and older. Defense Secretary Pete Hegseth has described the program as a readiness measure and said troops found deficient could be referred for supervised treatment, including testosterone replacement therapy. Physicians and medical groups continue to question broad testing of otherwise healthy service members, warning that uncertain screening thresholds could lead to unnecessary treatment and risks such as infertility.

Analysis & opinion

The arguments that emerged from this coverage — built only from the analysis and opinion pieces, never from straight reporting. Each dot is one article, placed by its outlet's bias — left to right. How to read our graphics →
angles sorted left-argued → right-argued
·

Macho culture stuntLeans Left

Hegseth’s testosterone push is a culture-war stunt rather than serious defense policy. It uses macho and MAGA ideas about masculinity to sell a readiness agenda that will not solve the military’s real problems.

Daily Beast
RedState
Rolling Stone
Gizmodo
Mother Jones

Dubious medical scienceLeft & Center

Routine testosterone screening for healthy service members is not medically justified without symptoms or specific clinical indications. Testosterone is not a general performance drug, and treating hormone levels as a proxy for fighting effectiveness misreads the science and can create health risks.

CBS News
MS NOW
New York Post
Raw Story
Slate

Get tomorrow's edition

Every side, every morning — free in your inbox.

More of today's stories

all of today's stories →